Advanced in Turcot Syndrome

Enrico Opocher

Padova, IT 
Advanced in Turcot Syndrome
Padova, IT 
OverviewLocationsClinical Research

Overview

Enrico Opocher practices in Padova, Italy. Mr. Opocher is rated as an Advanced expert by MediFind in the treatment of Turcot Syndrome. His top areas of expertise are Optic Glioma, Liver Cancer, Turcot Syndrome, Hepatectomy, and Endoscopy.

His clinical research consists of co-authoring 88 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Turcot Syndrome.

Gender
Male

Locations

Padova, Italy
Other Locations
Milan, Italy
San Remo, 18038, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma
Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma
Enrollment Status: Terminated
Publish Date: May 31, 2022
Intervention Type: Drug
Study Drugs: Vinblastine+Nilotinib, Vinblastine
Study Phase: Phase 2
PHASE I-II STUDY OF VINBLASTINE IN COMBINATION WITH NILOTINIB IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH REFRACTORY OR RECURRENT LOW-GRADE GLIOMA
PHASE I-II STUDY OF VINBLASTINE IN COMBINATION WITH NILOTINIB IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH REFRACTORY OR RECURRENT LOW-GRADE GLIOMA
Enrollment Status: Completed
Publish Date: May 27, 2022
Intervention Type: Drug
Study Drugs: Nilotinib, Vinblastine
Study Phase: Phase 1
View 1 Less Clinical Trial

88 Total Publications

Eye Salvage and Vision Preservation in High-Risk Intraocular Retinoblastoma Patients: Long-Term Results From the Prospective Phase II AIEOP RTB 012 Study.
Eye Salvage and Vision Preservation in High-Risk Intraocular Retinoblastoma Patients: Long-Term Results From the Prospective Phase II AIEOP RTB 012 Study.
Journal: Cancer medicine
Published: June 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Opocher's expertise for a condition
ConditionClose
    View All 26 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile